Adenocarcinoma, Bronchiolo-Alveolar  >>  Triapine (3-AP)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Triapine (3-AP) / Vion, Northwestern University
NCT00077415: 3-AP and Gemcitabine as Second-Line Therapy in Treating Patients With Stage III or Stage IV Recurrent Non-Small Cell Lung Cancer

Completed
2
31
RoW
gemcitabine hydrochloride, triapine
Cancer Therapeutics Research Group, National Cancer Institute (NCI)
Lung Cancer
01/08
02/08

Download Options